Zevra Therapeutics, Inc. (ZVRA)
NASDAQ: ZVRA · Real-Time Price · USD
11.86
+0.27 (2.33%)
Nov 9, 2026, 9:53 AM EST - Market open
Zevra Therapeutics Market Cap
Zevra Therapeutics has a market cap or net worth of $705.72 million as of November 9, 2026. It is the 12,190th most valuable company in the world and the 2,482nd biggest in the United States. Its market cap has increased by 42.28% in one year.
Market Cap
705.72M
Enterprise Value
511.38M
1-Year Change
42.28%
Global Rank
Country Rank
#2,482 United States
Category
ChartMarket Cap Chart
Since April 16, 2015, Zevra Therapeutics's market cap has increased from $137.80M to $705.72M, an increase of 412.14%. That is a compound annual growth rate of 15.16%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 9, 2026 | 705.72M | 39.91% |
| Dec 31, 2025 | 504.40M | 13.30% |
| Dec 31, 2024 | 445.20M | 87.69% |
| Dec 29, 2023 | 237.20M | 49.75% |
| Dec 30, 2022 | 158.40M | -48.50% |
| Dec 31, 2021 | 307.60M | 505.51% |
| Dec 31, 2020 | 50.80M | 303.17% |
| Dec 31, 2019 | 12.60M | -73.25% |
| Dec 31, 2018 | 47.10M | -20.71% |
| Dec 29, 2017 | 59.40M | 37.50% |
| Dec 30, 2016 | 43.20M | -84.95% |
| Dec 31, 2015 | 287.00M | 108.27% |
| Apr 16, 2015 | 137.80M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sana Biotechnology | 709.48M |
| Sagimet Biosciences | 698.45M |
| Attovia Therapeutics | 697.09M |
| Achieve Life Sciences | 691.50M |
| Aura Biosciences | 680.30M |
| 4D Molecular Therapeutics | 676.74M |
| ArriVent BioPharma | 672.56M |
| Candel Therapeutics | 669.54M |